CVS HEALTH Corp - Director's Dealing 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-10-26

Reporting Person: Brennan Troyen A (EVP and Chief Medical Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-26	Common Stock	M	80802	$54.19	Acquired	221003.059	Direct
2021-10-26	Common Stock	S	1955	$88.00	Disposed	219048.059	Direct
2021-10-26	Common Stock	S	80802	$88.00	Disposed	138246.059	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-26	Stock Option	$54.19	M	80802	Disposed	2029-04-01	Common Stock (80802)	Direct

Security	Shares	Ownership
Common Stock (restricted)	4805	Direct

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$102.26	2022-04-01	Common Stock (47937)	47937	Direct
Stock Option	$104.82	2023-04-01	Common Stock (53772)	53772	Direct
Stock Option	$78.05	2024-04-03	Common Stock (75134)	75134	Direct
Stock Option	$62.21	2025-04-01	Common Stock (21894)	21894	Direct
Stock Option	$58.34	2030-04-01	Common Stock (112637)	112637	Direct
Stock Option	$74.30	2031-04-01	Common Stock (99344)	99344	Direct

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F3: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F4: Option became exercisable in four equal annual installments, commencing 4/1/2017.

F5: Option became exercisable in four equal annual installments, commencing 4/3/2018.

F6: Option became exercisable in four equal annual installments, commencing 4/1/2019.

F7: The number of shares subject to the option were calculated using a 30-day average price.

F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.

F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.